Status:
COMPLETED
A Comparison Between Cognitive, Behavioral, and Cognitive-Behavioral Therapy for Generalized Anxiety Disorder
Lead Sponsor:
Michelle G. Newman
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study will evaluate the effectiveness of three adaptive coping treatments in lessening anxiety in adults with generalized anxiety disorder.
Detailed Description
Generalized anxiety disorder (GAD) is a common psychiatric disorder that affects nearly 6.8 million adults in the United States. GAD is characterized by persistent feelings of worry and anxiety that r...
Eligibility Criteria
Inclusion
- Primary diagnosis of GAD
Exclusion
- Diagnosis of any of the following: panic disorder, subclinical GAD, severe depression, psychosis, or organic brain syndrome
- Currently receiving therapy for GAD or has previously received CBT
- Medical contributions to anxiety
- Currently taking antidepressant medication
- Current substance abuse
Key Trial Info
Start Date :
October 1 1991
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 1998
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT00635999
Start Date
October 1 1991
End Date
October 1 1998
Last Update
January 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State University
University Park, Pennsylvania, United States, 16802